ArticleMicroorganisms2025

Impact of Switching from Oral to Long-Acting Injectable Cabotegravir and Rilpivirine on the Lipid Profile of HIV-Positive Patients.

Marta Segura Díaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.